Rejection of Mouse Renal Cell Carcinoma Elicited by Local Secretion of Interleukin‐2

We introduced the interleukin‐2 (IL‐2) gene into mouse renal cell carcinoma (RenCa) in order to examine the mechanism of tumor rejection. IL‐2 gene‐transfected RenCa (RenCa/IL‐2Hi) exhibited marked retardation of tumor growth when implanted in a syngeneic host. Growth retardation of RenCa/IL‐2Hi was...

Full description

Saved in:
Bibliographic Details
Published in:Cancer science 1996-07, Vol.87 (7), p.724-729
Main Authors: Hara, Isao, Hotta, Hak, Sato, Noriyuki, Eto, Hiroshi, Arakawa, Soichi, Kamidono, Sadao
Format: Article
Language:English
Subjects:
Animals
BCG Vaccine - immunology
Biological and medical sciences
Carcinoma, Renal Cell - immunology
Cytokines
Female
Graft Rejection
Growth rate
Host-tumor relations. Immunology. Biological markers
Immunological memory
Inflammation
Inflammation - etiology
Interleukin-2 - genetics
Interleukin-2 - metabolism
Interleukin‐2
Kidney cancer
Kidney Neoplasms - immunology
Lymphocytes T
Medical sciences
Memory cells
Mice
Mice, Inbred BALB C
Mice, Nude
Natural killer cells
Neoplasm Transplantation
Renal cell carcinoma
T-Lymphocytes - physiology
Transfection
Tumor rejection
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We introduced the interleukin‐2 (IL‐2) gene into mouse renal cell carcinoma (RenCa) in order to examine the mechanism of tumor rejection. IL‐2 gene‐transfected RenCa (RenCa/IL‐2Hi) exhibited marked retardation of tumor growth when implanted in a syngeneic host. Growth retardation of RenCa/IL‐2Hi was also observed in athymic nude mice even after depletion of natural killer (NK) cells by treatment with anti‐asialo GM1 antibody. Histological analysis of RenCa/IL‐2Hi tumors disclosed non‐specific inflammatory changes in syngeneic hosts. Co‐injection of Bacillus Calmette Guerin with RenCa/IL‐2Hi considerably enhanced the anti‐tumor effects. Taken together, these findings strongly suggest that in situ IL‐2 production leads to tumor rejection through non‐specific inflammatory responses without participation of T cells and NK cells. On the other hand, the syngeneic mice that had rejected RenCa/IL‐2Hi acquired immunity against parental RenCa, suggesting possible participation of memory T cells in the second rejection of the tumor.
ISSN:0910-5050
1347-9032
1349-7006
1876-4673
DOI:10.1111/j.1349-7006.1996.tb00284.x